Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency
Hayward, A.R.; Murphy, S.; Githens, J.; Troup, G.; Ambruso, D.
Journal of Pediatrics 100(4): 665-668
1982
ISSN/ISBN: 0022-3476 PMID: 7038081 Document Number: 192396
Document emailed within 1 workday
Related Documents
Sebnem Kilic, S.; Kavurt, S.; Balaban Adim, S. 2010: Transfusion-associated graft-versus-host disease in severe combined immunodeficiency Journal of Investigational Allergology and Clinical Immunology 20(2): 153-156Maeda, T.; Nomoto, K. 1995: Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels Journal of Rheumatology 22(12): 2259-2265
Rosenkrantz, K.; Keever, C.; Bhimani, K.; Horvath, A.; Brochstein, J.; O'Reilly, R.; Dupont, B.; Flomenberg, N. 1990: Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency Journal of Immunology 144(5): 1721-1728
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Fauser, A.A.; Shustik, C.; Langleben, A.; Laurent, G.; Kanz, L.; Spurll, G.M.; Price, G.; Ahlgren, P.D.; Cooper, B.A. 1988: T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 40-46
Park, B.H.; Good, R.A.; Gate, J.; Burke, B. 1974: Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease Transplantation Proceedings 6(4): 385-387
Lu, J.; Xu, L.-p.; Huang, X.-j.; Chen, H.; Zhang, Y.-c.; Ren, H.-y.; Guo, N.-l.; Lu, D.-p. 2003: Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody Zhonghua Yi Xue Za Zhi 83(3): 216-219
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Cahn, J.Y.; Bordigoni, P.; Tiberghien, P.; Milpied, N.; Brion, A.; Widjenes, J.; Lioure, B.; Michel, G.; Burdach, S.; Kolb, H.J. 1995: Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. a multicenter phase IIi study Transplantation 60(9): 939-942
Bowles, M.J.; Wood, R.F.; Pockley, A.G. 1996: Anti-graft and anti-host antibody responses following small bowel transplantation in the rat Transplantation Proceedings 28(5): 2486
Dosch, H.M.; Lee, J.W.; Gelfand, E.W.; Falk, J.A. 1978: Severe combined immunodeficiency disease: a model of T-cell dysfunction Clinical and Experimental Immunology 34(2): 260-267
Shaffer, D.; Simpson, M.A.; Milford, E.L.; Gottschalk, R.; Kut, J.P.; Maki, T.; Monaco, A.P. 1991: Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets Transplantation Proceedings 23(1 Pt 1): 679-681
Wall, D.A.; Hamberg, S.; Ferrara, J.L.; Abbas, A.K. 1989: Immunodeficiency in graft-versus-host disease (GVHD). II. Effects of GVHD-induced suppressor cells on CD4+ T cell clones Journal of Immunology 143(1): 74-78
Fast, L.D. 1991: In vitro characterization of a murine recipient anti-donor effector cell responsible for the development of chronic graft-versus-host disease Journal of Immunology 147(6): 1731-1738
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
You-Ten, K.E.; Lapp, W.S. 1996: The role of endogenous glucocorticoids on host T cell populations in the peripheral lymphoid organs of mice with graft-versus-host disease Transplantation 61(1): 76-83
Dey, B.; Yang, Y.G.; Preffer, F.; Shimizu, A.; Swenson, K.; Dombkowski, D.; Sykes, M. 1999: The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model Transplantation 68(1): 141-149
Ghetie, M.A.; Richardson, J.; Tucker, T.; Jones, D.; Uhr, J.W.; Vitetta, E.S. 1991: Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites Cancer Research 51(21): 5876-5880
Moroz, C.; Zaspin, E.; Shohat, B. 1996: An immunosuppressive effect of anti-p43 monoclonal antibody on human xenogeneic graft versus host response is mediated by CD8+ T cells Transplantation Proceedings 28(6): 3196-3198
Van Rappard-Van der Veen, F.M.; Kiesel, U.; Poels, L.; Schuler, W.; Melief, C.J.; Landegent, J.; Gleichmann, E. 1984: Further evidence against random polyclonal antibody formation in mice with lupus-like graft-vs-host disease Journal of Immunology 132(4): 1814-1820